Rare diseases
Investigational molecules
Locations
Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer
BelgiumStudy Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer
BelgiumStudy of Trastuzumab Deruxtecan for Patients with Unresectable or Metastatic HER2-low or HER2 IHC0 Breast Cancer
BelgiumStudy on Vilobelimab and Drug Combination for Treating Ulcerative Pyoderma Gangrenosum in Adults
BelgiumStudy on the Effects of Vitamin D3 in Patients with Periodontitis and Vitamin D Deficiency
BelgiumStudy of Pembrolizumab and Olaparib with Chemoradiation for Patients with Newly Diagnosed Limited-Stage Small Cell Lung Cancer
BelgiumStudy Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer
BelgiumStudy on the Effectiveness and Safety of CAM2029 Compared to Octreotide and Lanreotide in Patients with Gastroenteropancreatic Neuroendocrine Tumors
BelgiumStudy on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older
BelgiumStudy of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
BelgiumStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
BelgiumStudy on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
